I would add that the regulatory review of drugs and devices, R2D2, is actually including the use of foreign reviews as one of the projects. Again, Health Canada is the best organization to speak to that, but from what we hear from the regulators, they're already beginning to determine how that might happen and under what conditions. That kind of discussion is already under way.
On November 6th, 2018. See this statement in context.